Ondřej Vašíček Selected Research

pseurotin d

12/2022	Pseurotin D inhibits delayed type IV hypersensitivity response.
10/2021	Pseurotin D Induces Apoptosis through Targeting Redox Sensitive Pathways in Human Lymphoid Leukemia Cells.
4/2020	Natural pseurotins and analogs thereof inhibit activation of B-cells and differentiation into the plasma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ondřej Vašíček Research Topics

Disease

3	Inflammation (Inflammations) 03/2024 - 02/2020
2	Hypoxia (Hypoxemia) 01/2017 - 11/2016
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 12/2022
1	Lymphoid Leukemia 10/2021
1	Edema (Dropsy) 04/2020
1	Hypersensitivity (Allergy) 04/2020
1	Neoplasms (Cancer) 01/2019
1	Wounds and Injuries (Trauma) 11/2016
1	Infections 03/2011

Drug/Important Bio-Agent (IBA)

3	pseurotin dIBA 12/2022 - 04/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 01/2017
2	OvalbuminIBA 12/2022 - 04/2020
2	MelatoninIBA 02/2020 - 11/2016
1	HydrogelsIBA 03/2024
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 04/2020
1	N-acetylserotoninIBA 02/2020
1	AntioxidantsIBA 02/2020
1	Serotonin (5 Hydroxytryptamine)IBA 02/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2017
1	Glutathione (Reduced Glutathione)IBA 01/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	Hypoxia-Inducible Factor 1IBA 01/2017
1	Dual-Specificity PhosphatasesIBA 01/2017
1	Cyclizine (Marezine)FDA Link 03/2011
1	Antazoline (Antazoline Phosphate)FDA Link 03/2011
1	acrivastine (Semprex)FDA Link 03/2011
1	Histamine Antagonists (Antihistamines)IBA 03/2011